Skip to content

APOTHEEK VERSTRAETE

Active
Public limited companyfounded 1987active for 38 yearsVeldstraat(Kor) 156, 8500 Kortrijk, BelgiumKBO/BCE: BE 0432.663.055
Summary

APOTHEEK VERSTRAETE has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €386,320 and a net result of €236,967. Equity has been stable since 2018 (±0.1% per year). Its solvency ranks better than 39% of 5,039 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 02-12-1987 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 1 other
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.032.235.716 8500 Kortrijk, since 23-12-1987
Financial year end
31 December
Peppol
Reachable since 26-08-2025

Board and ownership

Board
  • MAVACODirector · since 30-06-2025 · permanent representative Vanfleteren Karolien
Shareholders
  • MAVACO30-06-2025 annual accounts of MAVACO

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€555,316
▼ 2.8%
Turnover
≈ €2.0m
estimated
Profit
€236,967
▼ 0.4%
Equity
€386,320
▲ 0.2%
Total assets
€1.5m
▲ 10.4%
Employees on 31-12-2025
4
=
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 1987Size: 3.3 FTE, total assets €1.5mLiquidity: current ratio 1.24, cash €172,259Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 51-3
equity 26.5% of total assets
Liquidity 28-11
short-term debt 69.0% · cash 11.8%
Profitability 89-2
return on assets 16.2%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025lowest value 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.2 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.24 (1.36 in 2024), below the usual 1.5. Short-term debt is 69% and cash 11.8% of total assets. 73.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 42% of them on solvency, 25% on liquidity, 84% on profitability and 40% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1987
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: 3.3 FTE, total assets €1.5m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Liquidity: current ratio 1.24, cash €172,259
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
24 days early
2024
26 days late
2023
12 days early
2022
24 days early
2021
31 days early
2020
29 days early
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 14 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €236,967 8 years View

Recent changes

  1. · Gazette deed Reappointment: MAVACO (director)Permanent representative: Vanfleteren Karolien
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as APOTHEEK VERSTRAETE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.7m, founded between 1986 and 1990.

CompanyTotal assetsGross margin
APOTHEEK VERSTRAETE Kortrijk€1.5m€0.6m
Pharmacie de Bavière Liège€1.4m€0.5m
APOTHEEK COPPIN Oostende€1.4m€0.6m
Apotheek Paul Vanderhaegen Waregem€1.3m€0.6m
APOTHEEK COENE Zonnebeke€1.2m€0.6m
APOTHEEK D. DUBOIS Kortrijk€1.7m€0.4m
Apotheek Vichte Anzegem€1.1m€0.6m
Full comparison

Key facts about APOTHEEK VERSTRAETE

What is the company number of APOTHEEK VERSTRAETE?
The company number of APOTHEEK VERSTRAETE is 0432.663.055. The VAT number is the same number with BE in front: BE 0432.663.055.
Where is APOTHEEK VERSTRAETE based?
The registered office is at Veldstraat(Kor) 156, 8500 Kortrijk.Company details
What does APOTHEEK VERSTRAETE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VERSTRAETE?
The legal form of APOTHEEK VERSTRAETE is Public limited company (NV).
When was APOTHEEK VERSTRAETE founded?
APOTHEEK VERSTRAETE was founded on 02-12-1987.
Is APOTHEEK VERSTRAETE still active?
Yes, APOTHEEK VERSTRAETE is an active enterprise in the KBO register.
How many employees does APOTHEEK VERSTRAETE have?
APOTHEEK VERSTRAETE had an average of 3.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK VERSTRAETE fall under?
In its 2025 annual accounts, APOTHEEK VERSTRAETE states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of APOTHEEK VERSTRAETE?
The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €555,316 and 47 comparable companies (NACE 477). It probably lies between €1.6m and €3.3m.
Is APOTHEEK VERSTRAETE profitable?
In financial year 2025, APOTHEEK VERSTRAETE made a profit of €236,967.
Where can I find the annual accounts of APOTHEEK VERSTRAETE?
APOTHEEK VERSTRAETE filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VERSTRAETE due?
APOTHEEK VERSTRAETE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.